Literature DB >> 15885679

Non-Hodgkin lymphoma and benzene exposure: a systematic literature review.

S H Lamm1, A Engel, D M Byrd.   

Abstract

Epidemiological papers that address an association between benzene exposure and non-Hodgkin lymphoma (NHL) were identified and separated by study design. Eighteen studies contained 21 study groups-11 population-based case-control study groups, 3 nested occupation-based case-control study groups and 7 occupational benzene cohort study groups. Petroleum industry studies were not included. Only two of these 21 study groups showed statistically significant associations. However, these were among workers with multiple exposures across industries. Eleven of the 21 study groups presented ratios less than one, two equaled one, and eight were greater than one. Over all, about as many cases were observed (404) as expected (390.0) for an observed to expected ratio of 1.04 (0.94-1.14). After removal of the studies with multiple chemical exposures problems, the observed was 359 cases with 373.2 cases expected, yielding an odds ratio of 0.96 (0.86-1.06). Further assessment of an association with NHL should document the benzene exposure and separate out the contribution of non-benzene exposures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885679     DOI: 10.1016/j.cbi.2005.03.027

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphoma.

Authors:  Kathryn Hughes Barry; Yawei Zhang; Qing Lan; Shelia Hoar Zahm; Theodore R Holford; Brian Leaderer; Peter Boyle; H Dean Hosgood; Stephen Chanock; Meredith Yeager; Nathaniel Rothman; Tongzhang Zheng
Journal:  Am J Epidemiol       Date:  2011-01-12       Impact factor: 4.897

2.  Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay Area.

Authors:  Gregory J Tranah; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

Review 3.  Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association.

Authors:  C Steinmaus; A H Smith; R M Jones; M T Smith
Journal:  Occup Environ Med       Date:  2008-04-16       Impact factor: 4.402

Review 4.  [Paradigm change in the assessment of myeloid and lymphoid neoplasms associated with occupational benzene exposure].

Authors:  Stefanie Beelte; Rainer Haas; Ulrich Germing; Paul-Josef Jansing
Journal:  Med Klin (Munich)       Date:  2009-04-01

5.  Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.

Authors:  Pablo Conesa-Zamora; Javier Ruiz-Cosano; Daniel Torres-Moreno; Ignacio Español; María D Gutiérrez-Meca; Javier Trujillo-Santos; Elena Pérez-Ceballos; Rocío González-Conejero; Javier Corral; Vicente Vicente; Miguel Pérez-Guillermo
Journal:  BMC Cancer       Date:  2013-05-07       Impact factor: 4.430

Review 6.  Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions.

Authors:  Jelle Vlaanderen; Qing Lan; Hans Kromhout; Nathaniel Rothman; Roel Vermeulen
Journal:  Environ Health Perspect       Date:  2010-09-29       Impact factor: 9.031

7.  Solvent exposure and malignant lymphoma: a population-based case-control study in Germany.

Authors:  Andreas Seidler; Matthias Möhner; Jürgen Berger; Birte Mester; Evelin Deeg; Gine Elsner; Alexandra Nieters; Nikolaus Becker
Journal:  J Occup Med Toxicol       Date:  2007-04-02       Impact factor: 2.646

8.  The benzene metabolite para-benzoquinone is genotoxic in human, phorbol-12-acetate-13-myristate induced, peripheral blood mononuclear cells at low concentrations.

Authors:  Götz Alexander Westphal; Jürgen Bünger; Nadine Lichey; Dirk Taeger; Angelika Mönnich; Ernst Hallier
Journal:  Arch Toxicol       Date:  2009-02-11       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.